Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Technol Health Care ; 32(1): 243-253, 2024.
Article in English | MEDLINE | ID: mdl-37483030

ABSTRACT

BACKGROUND: In recent years, lower limb walking exoskeletons have been widely used in the study of spinal cord injury (SCI). OBJECTIVE: To explore the effect of a lower limb walking exoskeleton on quality of life and functional independence in patients with motor complete SCI. METHODS: This was a multi-center, single blind, randomized controlled trial. A total of 16 SCI patients were randomly assigned to either the exoskeleton-assisted walking (EAW) group (n= 8) or the conventional group (n= 8). Both groups received conventional rehabilitation training, including aerobic exercise and strength training. The EAW group additionally conducted the exoskeleton-assisted walking training using an AIDER powered robotic exoskeleton for 40-50 minutes, 5 times/week for 8 weeks. World Health Organization quality of life-BREF (WHOQOL-BREF) and the Spinal Cord Independence Measure III (SCIM-III) were used for assessment before and after training. RESULTS: There was an increasing tendency of scores in the psychological health, physical health, and social relationships domain of WHOQOL-BREF in the EAW group after the intervention compared with the pre-intervention period, but there was no significant difference (P> 0.05). SCIM-III scores increased in both groups compared to pre-training, with only the conventional group showing a significant difference after 8 weeks of training (P< 0.05). CONCLUSION: A lower limb walking exoskeleton may have potential benefits for quality of life and activities of daily living in patients with motor complete SCI.


Subject(s)
Exoskeleton Device , Spinal Cord Injuries , Humans , Activities of Daily Living , Quality of Life , Single-Blind Method , Spinal Cord Injuries/rehabilitation , Walking , Lower Extremity
2.
Front Microbiol ; 13: 986480, 2022.
Article in English | MEDLINE | ID: mdl-36225368

ABSTRACT

This study is to investigate the changes of lymphocyte subsets and the gut microbiota in Chinese Han patients with spinal cord injury (SCI). We enrolled 23 patients with SCI and 21 healthy controls. Blood and fecal samples were collected. The proportion of lymphocyte subsets was detected by flow cytometry. 16S rDNA sequencing of the V4 region was used to analyze the gut microbiota. The changes of the gut microbiota were analyzed by bioinformatics. Correlation analysis between gut microbiota and lymphocyte subsets was performed. CD4 + cells, CD4 + /CD8 + ratio and CD4 + CD8 + cells in peripheral blood of SCI patients were significantly lower than those of the control group (P < 0.05). There was no significant difference in B cells and CIK cells between the SCI group and the control group. The gut microbiota community diversity index of SCI patients was significantly higher than that of healthy controls. In SCI patients, the relative abundance of Lachnospiraceae (related to lymphocyte subset regulation), Ruminococcaceae (closely related to central nervous system diseases), and Escherichia-Shigella (closely related to intestinal infections) increased significantly, while the butyrate producing bacteria (Fusobacterium) that were beneficial to the gut were dramatically decreased. Correlation analysis showed that the five bacterial genera of SCI patients, including Lachnospiraceae UCG-008, Lachnoclostridium 12, Tyzzerella 3, Eubacterium eligens group, and Rumencocciucg-002, were correlated with T lymphocyte subsets and NK cells. In the SCI group, the flora Prevotella 9, Lachnospiraceae NC2004 group, Veillonella, and Sutterella were positively correlated with B cells. However, Fusobacterium and Akkermansia were negatively correlated with B cells. Moreover, Roseburia and Ruminococcaceae UCG-003 were positively correlated with CIK cells. Our results suggest that the gut microbiota of patients with SCI is associated with lymphocyte subsets. Therefore, it is possible to improve immune dysregulation in SCI patients by modulating gut microbiota, which may serve as a new therapeutic method for SCI.

3.
Nanomaterials (Basel) ; 11(12)2021 Nov 30.
Article in English | MEDLINE | ID: mdl-34947605

ABSTRACT

Humulus scandens was first adopted as a biomass precursor to prepare biochars by means of a facile molten salt method. The optimized biochar exhibits a high specific surface area of ~450 m2/g, a rich porous structure and abundant oxygen functional groups, which demonstrate excellent adsorption performance for heavy metal ions. The isotherm curves fit well with the Langmuir models, indicating that the process is governed by the chemical adsorption, and that the maximum adsorption capacity can reach 748 and 221 mg/g for Pb2+ and Cu2+, respectively. In addition, the optimized biochar demonstrates good anti-interference ability and outstanding removal efficiency for Cu2+ and Pb2+ in simulated wastewater. The mechanism investigation and DFT calculation suggest that the oxygen functional groups play dominant roles in the adsorption process by enhancing the binding energy towards the heavy metal ions. Meanwhile, ion exchange also serves as the main reason for the effective removal.

SELECTION OF CITATIONS
SEARCH DETAIL
...